Technical Analysis for RGS - Regeneus Ltd
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Narrow Range Bar | Range Contraction | 12.50% | |
| Wide Bands | Range Expansion | 12.50% | |
| MACD Bearish Signal Line Cross | Bearish | 12.50% | |
| Wide Bands | Range Expansion | 12.50% | |
| Calm After Storm | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% |
| Alert | Time |
|---|---|
| Possible Pocket Pivot | 15 days ago |
| Gap Up Partially Closed | 15 days ago |
| Jack-in-the-Box Bullish Entry | 15 days ago |
| Rose Above Previous Day's High | 15 days ago |
| Rose Above Upper Bollinger Band | 15 days ago |
Get a Trading Assistant
Regeneus Ltd Description
Regeneus Ltd is a clinical-stage regenerative medicine company. The Company is engaged in developing cell-based therapies for human and animal health markets, with a focus on osteoarthritis and musculoskeletal disorders, as well as oncology and dermatology diseases. The Company's portfolio of therapeutic products is being developed using stem cell and immune oncology technology platforms. The Company's technology platform includes approximately three platforms across both human and animal health businesses, including Human and animal adipose-derived mesenchymal stem cells (MSCs) for the treatment of musculoskeletal diseases; Human and animal immunotherapy personalized cancer vaccine for the treatment of various cancers, and Stem cell secretions cell free supernatant (CFS) technology harnessing the therapeutic potential of mesenchymal stem cells for skincare treatments. The Company's products include Kvax, CryoShot, Progenza, Human Cancer Vaccine and Secretions Cream.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Medicine Biotechnology Disease Cancer Diseases Life Sciences Biology Cancers Therapeutic Product Therapy Disorders Therapeutic Products Oncology Regenerative Regenerative Medicine Stem Cell Stem Cells Cell Biology Technology Platforms Induced Stem Cells Mesenchymal Stem Cell Dermatology Immunotherapy
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.054 |
| 52 Week Low | 0.003 |
| Average Volume | 980,296 |
| 200-Day Moving Average | 0.010 |
| 50-Day Moving Average | 0.007 |
| 20-Day Moving Average | 0.008 |
| 10-Day Moving Average | 0.010 |
| Average True Range | 0.002 |
| RSI (14) | 52.38 |
| ADX | 31.43 |
| +DI | 40.851 |
| -DI | 20.426 |
| Chandelier Exit (Long, 3 ATRs) | 0.011 |
| Chandelier Exit (Short, 3 ATRs) | 0.010 |
| Upper Bollinger Bands | 0.014 |
| Lower Bollinger Band | 0.002 |
| Percent B (%b) | 0.58 |
| BandWidth | 145.679 |
| MACD Line | 0.001 |
| MACD Signal Line | 0.001 |
| MACD Histogram | -0.0002 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.011 | ||||
| Resistance 3 (R3) | 0.011 | 0.010 | 0.010 | ||
| Resistance 2 (R2) | 0.010 | 0.010 | 0.010 | 0.010 | |
| Resistance 1 (R1) | 0.010 | 0.010 | 0.010 | 0.010 | 0.010 |
| Pivot Point | 0.009 | 0.009 | 0.009 | 0.009 | 0.009 |
| Support 1 (S1) | 0.009 | 0.009 | 0.009 | 0.009 | 0.008 |
| Support 2 (S2) | 0.008 | 0.009 | 0.008 | 0.008 | |
| Support 3 (S3) | 0.008 | 0.008 | 0.008 | ||
| Support 4 (S4) | 0.008 |
